01450nam 2200361Ia 450 991069886630332120090512152926.0(CKB)5470000002397201(OCoLC)320850746(EXLCZ)99547000000239720120090512d2008 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] biological product deviation reporting for licensed manufacturers of biological products other than blood and blood componentsRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research :Center for Drug Evaluation and Research,[2006]i, 18 pages digital, PDF fileTitle from PDF title page (viewed on May 12, 2009)."October 2006".Includes bibliographical references (page 18).Guidance for industry Biological productsGovernment policyUnited StatesBiological productsGovernment policyCenter for Biologics Evaluation and Research (U.S.)Center for Drug Evaluation and Research (U.S.)GPOGPOBOOK9910698866303321Guidance for industry3434577UNINA